Variation in macular thickness in healthy eyes with or without myopia using optical coherent tomography

  • Sami Jalal Abdulsamad Department of ophthalmology, Hawler Teaching Hospital, Hawler Medical University, Erbil, Iraq.
  • Eman H. Alwan Department of ophthalmology, Hawler Teaching Hospital, Hawler Medical University, Erbil, Iraq.
  • Ahmad Kareem -------- Department of ophthalmology, Hawler Teaching Hospital, Hawler Medical University, Erbil, Iraq.
  • Ahmad Ismail ------ Department of ophthalmology, Hawler Teaching Hospital, Hawler Medical University, Erbil, Iraq.
Keywords: Macula, OCT, Age, Gender, Axial length

Abstract

Background and objective: Difference in macular thickness is affected by age, gender and axial length in any ethnic group. The aim of this study is to report normal macular thickness measurement in healthy Iraqi eyes using Optical Coherence Tomography mapping software. Methods: In this cross–sectional study, the macula of 150 eyes (75 healthy subjects) underwent a complete ophthalmic examination including Optical Coherence Tomography. Optical Coherence Tomography parameters of macular thickness were analyzed with baseline variables including age, gender and axial length. Results: Mean central foveal thickness were 217µm and mean macular thickness in 6mm diameter were 245µm. Macular thickness measurement were thinnest at the center of the fovea, thickest within 3mm diameter of the center, and diminish toward the periphery of the macula. The temporal quadrant was thinner than the nasal quadrant. No correlation was found between macular thickness and age. The difference between male and female was significant (P < 0.05). The macula thickness was significantly less in eyes with axial length more than 24mm and more in eyes with axial length less or equal to 24mm (P < 0.05). Conclusion: The macular thickness has a significant correlation with gender and axial length. This normal baseline data of macular thickness of the eyes of Iraqis living in Erbil may be a useful guideline for further research and management of glaucoma and macular diseases.

References

Kanski JJ. Clinical Ophthalmology: A systemic approach. 6th edition. London: Elsevier Science; 2006.

Koozekanani D, Roberts C, katz SE ,Herderick EE: intersession repeatability of macular thickness measurements with the humphrey. Invest Ophthalmol Vis Sci 2000;41(6):1486-91.

Merdith TA, Kenyon KR, Singerman LJ, Fine SL. Perifoveal vascular leakage and macular oedema after intracapsular cataract extraction. Br J Ophthalmol 1976;60:765-9.

Nussenblatt RB, Kaufman SC, Palestine AG, Davis MD, Ferris FL. 3rd Macular thickening and visual acuity. Measurement in patients with cystoids macular edema. Ophthalmol 1987;94(9):1134-9.

Skuta GL, Cantor LB, Weiss JS. Basic and Clinical Science Course. Glaucoma Section 10. San Francisco. USA: Am Acad Ophthalmol 2010; 10-50.

D Huang, EA Swanson, CP Lin, JS Schuman, WG Stinson, W Chang, et al. Optical coherence tomography. Science 1991;254:1178-81.

Koury CB. Prevalence of AMD in Whites, blacks, Hispanics Chinese. (cited 2011 Jan 15), available from: http://www.retinatoday.com/Html%20Pages/0306/Retina0306_Klein.pdf

Palacios S, Henderson VW, Siseles N, Tan D, Villaseca P. Age of menopause and impact of climacteric symptoms by geographical Region. Climacteric 2010; 13:419–28.

Bjornsson OM, Syrdalen P, Bird AC, Peto T, Kinge B: The prevalence of age-related maculopathy (ARM) in an urban Norwegian population: The Oslo macular study. Acta Ophthalmol Scand 2006; 84(5):636-41.

Schuman JS, Pedut-Kloizman T, Hertzmark E, Wilkins JR, Puliafito CA, Swanson EA, et al. Reproducibility of nerve fiber layer thickness measurement using optical coherence tomography. Ophthalmology 1996;103:1889-98.

Chan A, Duker JS, Tony HK, Fujimoto JG, Schuman JS. Normal Macular Thickness Measurements in Healthy Eyes Using Stratus Optical Coherence Tomography. Arch Ophthalmol 2006 ;124(2):193-8.

Song WK, Lee SC, Lee ES, Kim CY, Kim SS. Macular Thickness Variations with Sex, Age, and Axial Length in Healthy Subjects: A Spectral Domain–Optical Coherence Tomography Study. Invest Ophthalmol Vis Sci 2010;51(8):3913-8.

Konno S, Akiba J, Yoshida A. Retinal thick- ness measurement With opticalcoherence Tomography and the scanning Retinal thickness analyzer. Retina 2001; 21(1):57-61.

Massin P, Vicaut E, Haouchine B, Erginay A, Paques M, Gaudric A. Reproducibility of retinal mapping using optical coherence tomography. Arch Ophthalmol 2001;119:1135-42

Muscat S, Parks S, Kemp E, Keating D. Repeatability and reproducibility of macular thickness measurements with Humphrey OCT system. Invest Ophthalmol Vis Sci 2002; 43:490-5.

Chan A, Duker JS, Ko TH, Fujimoto JG, Schuman JS. Normal macular thickness measurements in healthy eyes using stratus optical coherence tomography. Arch Ophthalmol 2006; 124(2):193-8.

Chamberlain MD, Guymer RH, Dirani M, Hopper JL, Baird PN. Heritability of macular thickness determined by optical coherence tomography. Invest Ophthalmol Vis Sci 2006; 47(1):336-40.

Guedes V, Schuman JS, Hertzmark E, Wollstein G, Correnti A, Mancini R. Optical Coherence Tomography Measurement of Macular and Nerve Fiber Layer Thickness in Normal and Glaucomatous Human Eyes. Ophthalmology 2003; 110(1): 177–89.

Huang JJ, Liu X, Wu ZQ, Xiao H, Dustin L, Sadda S. Macular thickness measurements in normal eyes with time-domain and fourier-domain optical coherence tomography. Retina 2009; 29(7):980-7.

Wakitani Y, Sasoh M, Sugimoto M, Ito Y, Ido M, Uji Y. Macular thickness measurement in healthy subject with different axial lengths using optical coherence tomography. Retina 2003;23:177-82.

Elliot CS, Catanuto P, Fernandez P, Espinosa-Heidmann D, Karl M, Korach K, et al. Subtype Specific Estrogen Receptor Action Protects Against changes in MMP-2 Activation in Mouse Retinal Pigmented Epithelial Exp Eye. Endocr Res 2008; 86(4): 653–60.

Dincer Y, Ozen E, Kadioglu P, Hatemi H, Akcay T. Effect of sex hormones on lipid peroxidation in women with polycystic ovary syndrome, healthy women, and men. Endocr Res 2001;27(3):309-16.

Smith W, Mitchell P, Wang JJ. Gender, oestrogen, hormone replacement and age-related macular degeneration. Results from the blue mountains eye study. Aust N Z J Ophthalmol 1997; 25:S13-5.

Feskanich D, Cho E, Schaumberg DA, Colditz GA, Hankinson SE. Menopausal and reproductive factors and risk of age-related macular degeneration. Arch Ophthalmol 2008; 126(4):519-24.

Velez DR, Gallins P, Polk M, Ayala-Haedo J, Schwartz SG, Kovach JL, et al. Inverse association of female hormone replacement therapy and oral contraceptive use with age-related macular degeneration and interactions with arms2 polymorphisms. Invest Ophthalmol Vis Sci 2010;51(4):1873-9.

Published
2018-10-03
How to Cite
Abdulsamad, S., Alwan, E., --------, A., & ------, A. (2018). Variation in macular thickness in healthy eyes with or without myopia using optical coherent tomography. Zanco Journal of Medical Sciences (Zanco J Med Sci), 18(2), 746 - 750. https://doi.org/10.15218/zjms.2014.0027
Section
Original Articles